Polycystic Kidney Disease Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Polycystic Kidney Disease?
Polycystic kidney disease (PKD) is an inherited genetic disorder in which numerous fluid-filled cysts develop in the kidneys. As cysts grow and multiply, the kidneys may become enlarged, and their ability to filter blood can gradually decline. PKD can also affect organs outside the kidneys, particularly the liver and blood vessels. The two main forms are autosomal dominant PKD (ADPKD), which usually develops in adulthood, and autosomal recessive PKD (ARPKD), which often presents during infancy or childhood.
What is the Importance of Timely Treatment?
PKD may progress gradually without noticeable symptoms in its early stages. Timely diagnosis and regular monitoring can help detect high blood pressure, declining kidney function, increasing kidney volume and other complications. In adults with ADPKD who are at risk of rapid disease progression, appropriate assessment can help identify patients who may benefit from disease-modifying treatment such as tolvaptan. Early management of blood pressure and other complications can also help protect kidney function.
What are the Common Symptoms of Polycystic Kidney Disease?
- Pain in the back, sides or abdomen
- High blood pressure
- Blood in the urine
- Recurrent urinary tract or kidney cyst infections
- Kidney stones
- Increased abdominal fullness due to enlarged kidneys or liver cysts
- Headaches
- Fatigue
- Frequent urination or other urinary changes
- Reduced kidney function
- Swelling in advanced kidney disease
- Symptoms related to kidney failure in severe disease
Causes and Risk Factors of Polycystic Kidney Disease
Causes
- PKD is caused by disease-causing genetic variants that affect kidney cell development and function. ADPKD is most commonly associated with variants in the PKD1 or PKD2 genes and is usually inherited from one affected parent.
- ARPKD is caused by variants in the PKHD1 gene and occurs when a child inherits disease-causing variants from both parents.
- In some cases, a new genetic variant may occur without a known family history.
Risk Factors
- Having a parent with ADPKD
- Family history of PKD
- Inheriting disease-causing variants associated with PKD
- Having a sibling or close relative with PKD
- Genetic factors associated with more rapid disease progression
- High blood pressure, which can accelerate kidney damage
- Increasing kidney size or total kidney volume in ADPKD
- Reduced kidney function or evidence of rapid eGFR decline
Latest Research and Technologies in the Treatment of Polycystic Kidney Disease in India
- Recent advances in PKD management focus on early diagnosis, imaging-based risk assessment and slowing disease progression. MRI and other advanced imaging techniques can help quantify kidney size and cyst burden, while genetic testing can support diagnosis and family counselling in selected patients. Research continues into additional disease-modifying therapies, biomarkers and approaches aimed at slowing cyst growth and kidney-function decline.
Treatment options for Polycystic Kidney Disease
Peritoneal Dialysis (PD) : PD offers excellent, continuous fluid removal, gentler blood pressure control, and spares the patient from frequent needle sticks, making it a highly popular home-based option.
Cost Start From 70Explore Options
Hemodialysis (HD) : Hemodialysis allows for aggressive fluid removal during sessions to help manage fluid-dependent hypertension.
Cost Start From 80Explore Options
Kidney Transplantation : Advanced PKD may eventually cause kidney failure. Patients with kidney failure may require hemodialysis, peritoneal dialysis or kidney transplantation depending on their medical condition and eligibility.
Cost Start From 10000Explore Options
- Clinical assessment:
- Medical and Nephrological Evaluation: A detailed history assesses family history of PKD, blood pressure, urinary symptoms, flank or abdominal pain, kidney stones, urinary infections, blood in the urine and symptoms of declining kidney function.
- Kidney Function Assessment: Blood tests, including serum creatinine and estimated glomerular filtration rate (eGFR), assess kidney function. Urinalysis and urine protein or albumin measurements may help identify additional kidney abnormalities.
- Blood Pressure Assessment: Regular blood-pressure measurement is important because hypertension is common in ADPKD and can contribute to faster kidney-function decline and cardiovascular complications.
- Family and Genetic Assessment: A detailed family history can help identify inherited disease. Genetic testing may be considered when the diagnosis is uncertain, when there is no clear family history, for selected living kidney donors, or when information is needed for family or reproductive counselling.
- Risk and Prognostic Assessment: In adults with ADPKD, clinicians may assess the likelihood of rapid progression using kidney size, eGFR trajectory, age, and the PROPKD score. These assessments can help determine whether to consider disease-modifying treatment.
- Imaging Tests:
- Renal Ultrasound: Commonly used to detect kidney cysts and assess kidney size and structure.
- Magnetic Resonance Imaging (MRI): Provides detailed assessment of kidney and cyst volume and can support Mayo Imaging Classification for risk stratification.
- Computed Tomography (CT): May provide detailed anatomical information and can help evaluate kidney stones, bleeding, cyst complications or other abdominal conditions. Low-dose CT may also be considered for kidney-volume assessment when MRI is unavailable or unsuitable.
- Liver Imaging: Ultrasound, CT or MRI may be used to evaluate liver cysts and other abdominal complications.
- Brain Vascular Imaging: Magnetic resonance angiography (MRA) may be considered in selected patients to evaluate intracranial aneurysms, particularly when clinical or family-history factors indicate increased risk.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Polycystic Kidney Disease patients in India. These Services include:
- Physical Activity and Exercise: Regular, appropriate physical activity can help maintain strength, cardiovascular health and healthy body weight. Adapt activities when enlarged kidneys, pain, or other complications limit certain movements.
- Pain and Mobility Management: Physiotherapy may help patients manage chronic musculoskeletal discomfort, improve posture and maintain safe mobility. Patients with significantly enlarged or symptomatic kidneys may need individual assessment for high-impact or contact activities.
- Nutritional Support: A renal dietitian can guide sodium intake, healthy weight management, hydration, and other dietary considerations based on kidney function and blood pressure.
- Fatigue and Energy Management: Activity planning, adequate sleep, appropriate exercise and management of anemia or advanced kidney disease can help reduce the effect of fatigue on daily activities.
- Psychological and Long-Term Support: Counselling, genetic counselling and patient education can help individuals and families cope with an inherited condition, long-term monitoring, reproductive considerations and the possibility of future kidney replacement therapy.
- Medicines for PKD are used to control blood pressure, manage symptoms and, in selected patients with rapidly progressive ADPKD, slow the decline in kidney function. ACE inhibitors or ARBs may be used for blood-pressure control, while other antihypertensive medicines may be added when required. Pain medicines and antibiotics may be prescribed for cyst-related pain, infections, or other complications, depending on the underlying cause.
Instantly Connect with our Specialists
Hospitals for Polycystic Kidney Disease in India
Sri Ramachandra Medical Centre
Chennai, India
Sri Ramachandra Medical Centre located in Chennai, India is accredited by ISO, JCI, NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- The best minds in healthcare including specialists, and other healthcare professionals work together to treat patients with simple to complex and critical conditions.
- The number of inpatients and outpatients (annually) are 35,000 and 2,50,000 respectively.
- A wide range of surgical specialties, sub specialties are available in Sri Ramachandra Medical Centre Chennai.
- The bed capacity of the hospital is 800 which is inclusive of 200 Intensive Care Unit beds.
- Blood Bank and Eye Bank are available on a 24/7 basis.
Jaypee Hospital
Noida, India
Jaypee Hospital located in Noida, India is accredited by ISO, NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- 525 beds in the first phase
- 150 Critical Care beds
- 325 ward beds with Suite, Deluxe, Twin Sharing, and Economy options
- 18 Modular OTs
- 4 Cardiac Catheterization Lab with unqie Hybrid Operating Room
- 24 bedded Advanced Neonatal ICUs20 bedded Dialysis Units
- 2 Linear Accelerator (IMRT, VMAT, I
- GRT), Wide Bore CT Simulator, one Brachytherapy Suite
- True Beam STx Linear Accelerator
- 2 MRI (3.0 Tesla) with High-Intensity Focused Ultrasound
- 64 Slice PET CT, Gamma Camera, Dual Head 6 Slice SPECT CT
- 256 Slice CT Scan, CT Simulation
- Amongst the few GOLD LEED-certified hospital buildings in India
- Appointment Scheduling
- Flow motion 64 Slice PET CT technology
- Pick and drop facility from/to the Airport
- Foreign exchange facility
- Treatment packages
- Visa assistance
- Admission in the hospital
- Wi-Fi/internet service in the room
- Travel arrangement for patient & attendant after discharge
- Tele-consults after discharge
- Dedicated Guest House for International Patients maintained by Jaypee Hospital
- In-house translators for patient’s comfort
- Assistance in getting doctor’s opinion
- Registration with the Foreigners Regional Registration Office
- Accommodation arrangements after discharge
- Accommodation arrangement for the accompanying attendant
- Customized diet for patient and attendant
- Laundry services
- Prayer room
- Dialysis facility for 60 patients
- Cadaver organs
- Blood bank facilities
- Advanced Laboratory facilities
- Diagnostic and Radiology facilities
- High-end Ultrasound facilities
Fortis Hiranandani Hospital
Mumbai, India
- Fortis Hiranandani Hospital, Vashi, Navi Mumbai, is a leading NABH-accredited multi-super speciality hospital offering advanced tertiary care with over 150 beds.
- The hospital is known for clinical excellence in Cardiac Sciences, Oncology, Neurology, Orthopaedics, Organ Transplants, Urology, Gastroenterology, and Critical Care.
- With a strong team of experienced doctors, modern medical technology, and international patient services, the hospital provides comprehensive and patient-focused treatment.
- It maintains high standards of safety, hygiene, and quality care, making it a trusted healthcare destination in the Mumbai Metropolitan Region.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Polycystic Kidney Disease Treatment?
- Multidisciplinary Nephrology Care: Patients can access nephrologists, urologists, genetic specialists, radiologists, transplant specialists, and other professionals as needed.
- Advanced Diagnostic Facilities: Major centres may provide renal ultrasound, MRI, CT, genetic testing, kidney-function assessment and imaging-based progression-risk evaluation.
- Disease-Modifying Treatment: Eligible patients with rapidly progressive ADPKD may be evaluated for treatments such as tolvaptan under specialist supervision.
- Kidney Replacement Therapy: Advanced kidney centres can provide hemodialysis, peritoneal dialysis and kidney transplantation for patients who develop kidney failure.
- Comprehensive International Patient Support: Major hospitals may provide medical-record review, specialist consultations, treatment coordination, accommodation assistance and follow-up care for international patients.
Frequently Asked Questions
PKD is a lifelong genetic condition and does not have a fixed recovery period. Symptoms and complications can often be managed for many years, while some patients gradually develop chronic kidney disease. Patients who develop kidney failure may require long-term dialysis or kidney transplantation.
Yes. Most people with PKD can walk and remain physically active. Regular appropriate activity can support cardiovascular health and overall fitness. However, abdominal or flank pain, enlarged kidneys, fatigue, or advanced kidney disease may affect exercise tolerance, so adapt activities based on individual medical advice.
Major Indian nephrology centres may provide renal ultrasound, MRI, CT, genetic testing, kidney-function monitoring and specialised assessment of disease progression. Selected centres may also provide tolvaptan-based treatment, dialysis and kidney transplantation where clinically appropriate.
Many major Indian hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.
Consider a nephrology centre with experience in inherited kidney disorders and access to advanced imaging, genetic evaluation, blood-pressure management and kidney-function monitoring. For patients with progressive disease, consider centres that can provide disease-modifying treatment, dialysis and kidney transplantation when required.
There is no single success rate for PKD treatment because the condition is lifelong and its progression varies considerably. Outcomes depend on the type of PKD, genetic factors, kidney function, blood pressure, rate of cyst growth, complications and response to treatment. Management aims to control complications and, in selected ADPKD patients, slow kidney-function decline.
Nephrologists at specialised Indian centres manage PKD and its complications, including high blood pressure, cyst-related problems, declining kidney function and kidney failure. Complex cases may require collaboration between nephrology, genetics, radiology, urology and transplant teams.
Risks depend on the treatment used. Blood-pressure medicines may cause treatment-specific adverse effects, while tolvaptan can cause increased urination, dehydration and potentially serious liver injury and therefore requires specialist monitoring. Procedures for symptomatic cysts may have procedural risks. Dialysis and kidney transplantation also carry treatment-specific risks that should be discussed with the treating team.
PKD is not an injury. Sudden severe flank or abdominal pain, significant blood in the urine, fever with kidney or abdominal pain, markedly reduced urine output, severe headache, neurological symptoms, or difficulty breathing require prompt medical evaluation. Severe or sudden symptoms may indicate complications such as cyst bleeding, infection, kidney stones, worsening kidney function or, in selected patients, a serious vascular complication.
PKD does not typically cause structural physical deformities. However, progressive kidney enlargement, chronic pain, liver cysts and advanced kidney disease can affect physical function and daily activities. Severe kidney disease may eventually require dialysis or kidney transplantation.
Yes. Chronic pain, high blood pressure, fatigue, repeated infections, dietary and medication requirements, enlarged kidneys, liver cysts and progressive kidney disease can affect work, physical activity, travel and emotional well-being. Appropriate monitoring and treatment can help manage complications and support daily functioning.
Yes. Untreated or inadequately managed PKD can lead to progressive kidney enlargement, high blood pressure, declining kidney function and eventually kidney failure. PKD may also cause liver cysts, kidney stones, cyst infections and other complications. Some patients with ADPKD also have an increased risk of intracranial aneurysms.
PKD is a genetic condition and cannot currently be prevented in someone who inherits the disease-causing genetic variant. However, genetic counselling can help affected individuals and families understand inheritance and reproductive considerations. For people living with PKD, controlling blood pressure, maintaining a healthy lifestyle, avoiding smoking and following regular kidney monitoring can help reduce complications and may slow disease progression.
PKD can affect people of different ages, races and ethnic backgrounds. ADPKD is the most common form and is usually diagnosed in adulthood, while ARPKD is much rarer and often presents during infancy or childhood. Having a parent with ADPKD substantially increases the likelihood of inheriting the condition because the disease is commonly passed from one affected parent.